Best Momentum Stocks to Buy for July 3rd
Yahoo Finance · 4 hours ago
Open | 154.04 |
High | 155.95 |
Low | 151.25 |
Mkt Cap | 14.47B |
P/E (TTM) | 356.07 |
Div & Yield | N/A & N/A |
Prev. Close | 154.20 |
52 Wk. Low | 55.25 |
52 Wk. High | 173.25 |
Related stocks
Biopharmaceutical company
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 413.46M | 63.10% ▲ |
Net Income | 36.12M | - |
Diluted EPS | 0.37 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.02 | - |
Q1 2024 | -$0.07 | $0.37 |
Q4 2023 | $0.01 | $0.47 |
S&P 500^GSPC | 5,537.02+28.01 (+0.51%) |
Dow 30^DJI | 39,308.00-23.85 (-0.06%) |
Nasdaq^IXIC | 18,188.30+159.54 (+0.88%) |
Koss CorporationKOSS | 10.63+143.81% |
128.28+4.57% | |
Broadcom Inc.AVGO | 1,729.22+4.33% |